Knowing that people with disabilities would be especially vulnerable during the pandemic to problems with healthcare access and other issues, the Harvard Law School Project on Disability turned its attention early on to COVID-related initiatives and advocacy.
Health law has become especially timely in this year of COVID-19 vaccines and revitalized Obamacare. But for graduating student Phebe Hong ’21, it’s a passion that began in high school.
I. Glenn Cohen ’03 and Carmel Shachar J.D./M.P.H. ’10 of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics discuss the Biden administration’s healthcare agenda.
What are the ramifications of this pandemic year for medical practitioners? And how might the future of health care be shaped by the wounds inflicted on those we entrust with our lives?
On February 11, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School announced the formation of its new advisory board.
Should smoking be among the pre-existing health risks that qualify people for priority access to the COVID-19 vaccine? Harvard Law public health expert Carmel Shachar says the answer is yes.
The Petrie-Flom Center at Harvard Law School is joining forces with the Solomon Center for Health Law and Policy, its counterpart at Yale Law School, to host a seminar series reflecting on ethical and legal issues raised by the COVID-19 pandemic.
Public health expert Carmel Shachar discusses the COVID-19 vaccine, who is likely to get it first, and whether people can be required to get vaccinated.
Experts gathered this week to discuss the ethical, social, and legal implications of technological advancements that facilitate the early detection of dementia.
Cass Sunstein ’78, Robert Walmsley University Professor and former Administrator of the White House Office of Information and Regulatory Affairs in the Obama administration, believes “Nudge theory” might help bridge the gap between supply and demand for organ transplants.
